Indian Journal of Applied Basic Medical Sciences Year: 2020, Volume: 22(B), Issue. (2) First page: (446) Last page: (452) Online ISSN: 2249-7935 Print ISSN: 0975-8917 doi: 10.48165/ijabms.2020.22237
Histopathological Study of Prostatic Lesions
Harsha Gajjar1,Aashka Shah2*,Biren Parikh3, J.M.Shah4
1Assistant Professor pathology, 22nd year Resident pathology, 3Assistant Professor pathology, 4Professor and Head of pathology, Department of Pathology, AMC MET Medical College, Ahmedabad-380008
Corresponding author email id: email@example.com
Online Published on 02-July-2020
Background: Prostatic disease is responsible for significant morbidity and mortality in men throughout the world. Prostate cancer and benign prostatic hyperplasia are the two major prostate diseases that increase with aging. Histopathological examination of prostatic lesions has been gold standard for the final diagnosis. Objective: This study was carried out for histopathological evaluation of prostatic lesion and its correlation with the clinical data. Materials and Methods: This study included all types of prostatic specimens received in department of Pathology, AMC MET Medical College, Ahmedabad from January 2018 to December 2018. Relevant clinical data was recorded. Results: The most common age group presenting with prostatic lesion was 60-69 years and the most common presenting clinical symptom was difficulty in micturation. The frequency of benign and malignant lesions was observed to be 91% and 9% respectively. Amongst the benign lesions all lesions were Benign Prostatic Hyperplasia (BPH) with or without associated pathological lesions. All the malignant lesions were adenocarcinoma of prostate and were graded according to Gleasons scoring system. Predominant malignant lesions (40%) revealed Gleasons score 9. Strong correlation of S.PSA level with prostatic adenocarcinoma was seen in our study Conclusion: Histopathological evaluation seems to be gold standard for diagnosis, prognosis and management of prostatic lesions. S.PSA level has strong correlation with the risk and outcome of prostatic cancer.
Prostate, Benign Prostatic Hyperplasia (BPH), Adenocarcinoma, Histopathology, S.PSA (Prostate Specific Antigen)